Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Kate Plummer

Boots and Superdrug cough medicines withdrawn over safety fears

ALAMY

Cough and cold medicines from the country’s top pharmacies have been withdrawn from sale over risks patients could suffer an allergic reaction.

Watchdog, the Medicines and Healthcare products Regulatory Agency (MHRA), said products containing pholcodine should be withdrawn over concerns those taking them may experience a severe allergic reaction to muscle relaxants (neuromuscular blocking agents) they contain.

Around half of all general anaesthetics are thought to use these blocking agents that are used during general anaesthesia in surgery.

The risk of suffering a severe allergic reaction, or anaphylaxis, is thought to affect people who have taken a cough or cold product containing pholcodine in the 12 months before having surgery.

Dr Alison Cave, MHRA chief safety officer, said: “Safety is our top priority, and we keep the safety of medicines under continual review.

“Following a thorough scientific safety review of all the available evidence on pholcodine, together with advice from the independent Commission on Human Medicines, it has been recommended, as a precautionary measure, that these products should no longer be used.

“If you are taking a cough or cold medicine, check the packaging, label or patient information leaflet to see if pholcodine is a listed ingredient.

“If it is, and you have any questions, you can talk to your pharmacist who will suggest an alternative medicine.”

Dr Cave said anyone due to have an operation under general anaesthesia should tell the anaesthetist if they think they have used pholcodine, particularly in the past 12 months.

“The anaesthetist will be well placed to take this into account,” she said. “Anaesthetists are highly trained in managing anaphylaxis.”

The European Medicines Agency recommended the withdrawal of pholcodine medicines from the European market in December last year.

In the UK, healthcare workers have been told to stop supplying the products “immediately” and “quarantine all remaining stock”.

Professor Claire Anderson, president of the Royal Pharmaceutical Society, said: “If you are taking a cough medicine (including tablets and syrups), check the packaging, label or patient information leaflet to see if pholcodine is a listed ingredient – if it is, and you have any questions, you can talk to your pharmacist who can suggest a different medicine suitable for you.

“The risk to patients who have used pholcodine is very small. If you are due to have surgery, please speak to your pharmacist or medical team for advice.

“A cough usually clears up within three to four weeks. You can treat it with other cough medicines or hot lemon and honey (not suitable for babies under one year old).

“Rest up if possible and you can try paracetamol or ibuprofen, if suitable, to treat any pain. If your cough persists for longer than three to four weeks seek advice from a healthcare professional.

“This withdrawal is needed as safety of patients is paramount and we support efforts to ensure that all medicines on the market are safe and effective.”

The medicines listed by the MHRA as being recalled are:

The Boots Company PLC

Boots Night Cough Relief Oral Solution, PL 00014/0230

Boots Dry Cough Syrup 6 Years+, PL 00014/0523

Boots Day Cold & Flu Relief Oral Solution, PL 00014/0565

Thornton & Ross Limited

– Cofsed Linctus, PL 00240/0097

– Care Pholcodine 5mg/5ml Oral Solution Sugar Free, PL 00240/0101

– Galenphol Linctus, PL 00240/0101

– Galenphol Paediatric Linctus, PL 00240/0102

– Galenphol Strong Linctus, PL 00240/0103

– Covonia Dry Cough Sugar Free Formula, PL 00240/0353

Bell Sons & Company (Druggists) Limited

– Pholcodine Linctus Bells Healthcare 5mg Per 5ml Oral Solution, PL 03105/0059

– Numark Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059

– Well Pharmaceuticals Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059

– Superdrug Pholcodine Linctus BP, PL 03105/0059

– Strong Pholcodine Linctus BP, PL 03105/0060

Pinewood Laboratories Limited

– Pholcodine Linctus BP, PL 04917/0002

– Strong Pholcodine Linctus BP, PL 04917/0005

LCM Limited

– Pholcodine Linctus, PL 12965/0030

Glaxosmithkline Consumer Healthcare (UK) Trading Limited

– Day & Night Nurse Capsules, PL 44673/0068

– Day Nurse Capsules, PL 44673/0069

– Day Nurse, PL 44673/0075

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.